You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 14, 2024

CLINICAL TRIALS PROFILE FOR PREGNYL

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Pregnyl

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00415766 ↗	Comparison Between Recombinant Versus Urinary hCG for Ovulation Induction in High Responders	Unknown status	Eugonia	Phase 4	2013-06-01	The purpose of this study is to compare the clinical outcomes of recombinant human chorionic gonadotrophin (rHCG) and urinary HCG (uHCG) in patients undergoing IVF cycles.
NCT00415792 ↗	Comparison Between hCG and GnRH Agonist for Ovulation Induction in Patients With High Response to IVF Drugs	Unknown status	Eugonia	Phase 4	2003-11-01	hCG and GnRH agonist can be used to induce final oocyte maturation and ovulation in IVF cycles. These two approaches will be compared in this study in terms of pregnancy rates and embryological data using patients with hyper-response to IVF drugs.
NCT00627406 ↗	Triggering of Final Oocyte Maturation With GnRHa (Buserelin) in GnRH Antagonist Cycles	Completed	Regionshospitalet Viborg, Skive	Phase 4	2009-01-01	The purpose of this study is to possibly further improve the clinical outcome and explore the incidence of OHSS in patients, who have final oocyte maturation with GnRHa (Buserelin) in GnRH antagonist IVF/ICSI cycles
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for Pregnyl

Condition Name

Chart
Table

Condition Name for Pregnyl
Intervention	Trials
Infertility	12
Polycystic Ovary Syndrome	5
Invitro Fertilization	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for Pregnyl
Intervention	Trials
Infertility	16
Polycystic Ovary Syndrome	5
Infertility, Female	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for Pregnyl

Trials by Country

Map
Table

Trials by Country for Pregnyl
Location	Trials
Egypt	10
Belgium	5
United States	4
Greece	4
Iran, Islamic Republic of	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for Pregnyl
Location	Trials
Minnesota	2
Connecticut	1
Washington	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for Pregnyl

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for Pregnyl
Clinical Trial Phase	Trials
Phase 4	15
Phase 3	1
Phase 2/Phase 3	5
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for Pregnyl
Clinical Trial Phase	Trials
Completed	18
Unknown status	11
Terminated	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Pregnyl

Sponsor Name

Chart
Table

Sponsor Name for Pregnyl
Sponsor	Trials
Universitair Ziekenhuis Brussel	3
Cairo University	3
Lito Maternity Hospital	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for Pregnyl
Sponsor	Trials
Other	47
Industry	3
NIH	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.